The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commercial Development Agreement with Valkor

11 Apr 2022 08:28

RNS Number : 9285H
Quadrise Fuels International PLC
11 April 2022
 

11 April 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Commercial Development Agreement with Valkor Technologies LLC

 

Quadrise is pleased to announce the execution of a phased Commercial Development Agreement ("CDA") with Valkor Technologies LLC ("Valkor") headquartered in Park City, Utah, to commercialise Quadrise's MSAR® and bioMSAR™ technology at Valkor's projects in Utah state in the USA.

 

Under Phase 1 of the CDA, to be completed by 30 June 2022:

 

· Valkor will deliver a crude oil sample from a heavy oil asset in Utah in which they have an existing equity interest (the 'Primary Project') to Quadrise.

· Quadrise will perform analysis and testing on the sample to confirm that it is suitable to produce MSAR® and bioMSAR™.

· Quadrise and Valkor will together and in the same time frame:

o Negotiate supply agreements with identified target consumers of MSAR® and bioMSAR™ fuel to be produced by the Primary Project.

o Finalise the technical and operational requirements and commercial terms for license and supply of QFI technology.

Full commercial terms for an MSAR® and/or bioMSAR™ License and Supply Agreement at the Primary Project would then be concluded no later than October 2022.

 

Under Phase 2 of the CDA, following the conclusion of a License and Supply Agreement covering the Primary Project, Quadrise intends to grant Valkor exclusive terms over the deployment of QFI technology in the State of Utah. This is expected to take the form of further Licence and Supply Agreement(s) or Tolling Agreement(s) for projects on which QFI technology is proposed to be deployed.

 

Net profits generated under the License and Supply Agreement(s) or Tolling Agreement(s) are to be shared between Quadrise and Valkor, based on the respective contribution by each party to the deployment of QFI technology for each project.

Jason Miles, CEO of Quadrise Fuels International, commented:

"The need for more economical and lower carbon industrial and marine fuels has never been more apparent. Quadrise is delighted to have executed this agreement and looks forward to working expeditiously with the Valkor team to conclude commercial agreements for supply of MSAR® and bioMSAR™ for identified projects."

Steven Byle, CEO of Valkor, added:

"We are delighted to work jointly with Quadrise to secure high value opportunities for our Utah heavy sweet oil projects, following the successful testing completed on oil sands samples from the pilot plant last year. The supply and licensing of MSAR® technology in Utah is conditional on securing the first opportunity for fuel supply and offtake, and we look forward to working closely with Quadrise during the coming months on this commercial opportunity."

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

Notes to Editors

 

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFIFEESTILLIF
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSRoyalty Agreement
24th Feb 20147:00 amRNSUpdate on active programmes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.